HomeNewsIndiaCOVID-19: HUL donates over 74,000 RT-PCR testing kits

COVID-19: HUL donates over 74,000 RT-PCR testing kits

HUL Chairman and Managing Director Sanjiv Mehta said, "Sufficient supply of testing kits and other medical equipment will help frontline warriors competently tackle the COVID-19 virus."

June 02, 2020 / 20:54 IST
Story continues below Advertisement

FMCG major Hindustan Unilever Ltd (HUL) on Tuesday said it has donated 74,328 RT-PCR COVID-19 testing kits worth Rs 13 crore to help ramp up testing of patients in the country.

While Maharashtra has received about 28,800 RT-PCR testing kits, Indian Council of Medical Research has got 20,160 kits. Metropolis Labs has received 8,088 kits and Apollo Hospitals has got 17,280 kits, the company said in a statement.

Story continues below Advertisement

HUL Chairman and Managing Director Sanjiv Mehta said, "Sufficient supply of testing kits and other medical equipment will help frontline warriors competently tackle the COVID-19 virus."

Coronavirus India News LIVE Updates

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show